Impact of disease evolution on efficacy outcomes from larotrectinib in patients with locally advanced or metastatic tropomyosin receptor Kinase fusion-positive solid tumors
Nom du journal : JCO Precis Oncol
Année : 2021
Volume : 5
Page de départ : PO.21.00089